Microscopic observation drug-susceptibility assayvs. Xpert®MTB/RIF for the diagnosis of tuberculosis in a rural African setting: a cost-utility analysis-Reference-Cited by-同舟云学术

Microscopic observation drug-susceptibility assayvs. Xpert®MTB/RIF for the diagnosis of tuberculosis in a rural African setting: a cost-utility analysis

Published:2017-05-02 Issue:6 Volume:22 Page:734-743
ISSN:1360-2276
Container-title:Tropical Medicine & International Health
language:en
Short-container-title:Trop Med Int Health

Author:

Wikman-Jorgensen Philip E.¹²,Llenas-García Jara²³,Pérez-Porcuna Tomàs M.¹⁴,Hobbins Michael⁵,Ehmer Jochen⁵,Mussa Manuel A.⁶,Ascaso Carlos¹

Affiliation:

1. Department of Public Health; University of Barcelona; Barcelona Spain

2. SolidarMed Mozambique; Ancuabe Mozambique

3. Infectious Diseases Unit; Hospital General Universitario de Elche; Alicante Spain

4. Research Unit; Paediatrics Department; CAP Valldoreix; Mutua Terrassa Foundation; Mutua Terrassa University Hospital; Terrassa Catalunya Spain

5. SolidarMed Switzerland; Luzern Switzerland

6. Provincial Health Directorate; Operational Research Nucleus of Pemba; Pemba Mozambique

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Parasitology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tmi.12879/fullpdf

Reference50 articles.

1. WHO Global Tuberculosis Report 2015 2015 http://apps.who.int/iris/bitstream/10665/191102/1/9789241565059_eng.pdf

2. WHO Epidemiological Fact Sheet on HIV and AIDS Core data on epidemiology and response Mozambique WHO Geneva 2008

3. WHO WHO Global Tuberculosis Report 2014 2014 http://www.who.int/tb/publications/global_report/en/

4. HIV infection-related tuberculosis: clinical manifestations and treatment;Sterling;Clin Infect Dis,2010

5. Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa;Mukadi;AIDS,2001

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rethinking Tuberculosis Morbidity Quantification: A Systematic Review and Critical Appraisal of TB Disability Weights in Cost-Effectiveness Analyses;PharmacoEconomics;2024-08-07

2. Cost-Utility Analysis of Molecular Testing for Tuberculosis Diagnosis in Suspected Pulmonary Tuberculosis in Thailand;ClinicoEconomics and Outcomes Research;2022-02

3. Economic Analyses of Respiratory Tract Infection Diagnostics: A Systematic Review;PharmacoEconomics;2021-07-15

4. Inclusion of Additional Unintended Consequences in Economic Evaluation: A Systematic Review of Immunization and Tuberculosis Cost-Effectiveness Analyses;PharmacoEconomics - Open;2021-05-04

5. Cost-effectiveness analysis of Xpert in detecting Mycobacterium tuberculosis: A systematic review;International Journal of Infectious Diseases;2020-06